[Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines] [0.03%]
西班牙肾脏病学会关于SARS-CoV-2疫苗的立场声明
Emilio Sánchez-Álvarez,Borja Quiroga,Patricia de Sequera;en representación de la Junta Directiva de Sociedad Española de Nefrología
Emilio Sánchez-Álvarez
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide over the last year causing more than one million deaths. Several treatments have tried to modify the natural history of the coronavirus disease 2019 (COVID-19...
[Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?] [0.03%]
肾移植受者使用轻中度新冠肺炎治疗药物的真实世界经验:慢性肾脏病患者今后如何用药?
Marta Alonso,Florentino Villanego,Luis Alberto Vigara et al.
Marta Alonso et al.
[Tixagevimab-cilgavimab as pre-exposure prophylactic treatment against SARS-CoV-2 in kidney transplantation patients] [0.03%]
替沙格韦单抗-西加韦单抗作为肾移植患者预防性治疗新冠病毒感染的疗效及安全性分析
Luis Bravo González-Blas,Natalia Menéndez García,María Fernández Prada et al.
Luis Bravo González-Blas et al.
Introduction: It has been reported that after vaccination with RNAm or viral vectors from SARS-CoV-2 a significant number of solid organ transplant recipients do not develop an effective immune response. In this scenario,...
[Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: Renal replacement therapy and mortality. FRA-COVID SEN Registry Data] [0.03%]
急性COVID-19相关性肾损伤住院患者的特征、肾脏替代治疗及死亡率:FRA-COVID SEN注册研究数据
Mercedes Salgueira,Marina Almenara,Antonio Gutierrez-Pizarraya et al.
Mercedes Salgueira et al.
Background and objectives: Acute kidney injury (AKI) is common among hospitalized patients with COVID-19 and associated with worse prognosis. The Spanish Society of Nephrology created the AKI-COVID Registry to characteriz...
Amnuay Kleebayoon,Viroj Wiwanitkit
Amnuay Kleebayoon
Lessons from SENCOVAC: a prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum [0.03%]
来自SENCOVAC前瞻性研究的启示:评估CKD患者对SARS-CoV-2疫苗接种的反应
Borja Quiroga,María José Soler,Alberto Ortiz et al.
Borja Quiroga et al.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has negatively impacted on patients of the whole CKD spectrum, causing high rates of morbi-mortality. SARS-CoV-2 vaccines opened a new era, but patients with CKD (including kidney...
[Acute kidney injury and nephrotic syndrome secondary to COVID-19-associated focal segmental glomerulosclerosis] [0.03%]
COVID-19相关节段性肾小球硬化继发的急性肾损伤和肾病综合征
Amir Shabaka,Sofía Rovirosa-Bigot,Carmen Guerrero Márquez et al.
Amir Shabaka et al.
[Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients] [0.03%]
《SARS-CoV-2冠状病毒大流行(COVID-19)在肾移植患者管理的建议更新》
Verónica López,Auxiliadora Mazuecos,Florentino Villanego et al.
Verónica López et al.
SARS-CoV-2 infection (COVID-19) has had a significant impact on transplant activity in our country. Mortality and the risk of complications associated with COVID-19 in kidney transplant recipients (KT) were expected to be higher due to thei...
[Update of the prevention and isolation measure recommendations against SARS-COV-2 in dialysis units of Spain: A position paper of the Spanish Society of Nephrology Council] [0.03%]
西班牙西班牙肾脏病学会理事会关于西班牙血液透析单位预防和隔离措施的建议更新:立场文件
Patricia de Sequera,Borja Quiroga,Marian Goicoechea;en representación de la Junta Directiva de la Sociedad Española de Nefrología (S.E.N.)
Patricia de Sequera
SARS-CoV-2 pandemic has changed across the last 2 years. The development and approval of SARS-CoV-2 vaccines and the emergence of new variants has opened up a new scenario. On this regard, Spanish Society of Nephrology (S.E.N.) Council cons...
Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry [0.03%]
免疫抑制方案对肾脏移植受者COVID-19死亡率的影响:来自哥伦比亚一个移植中心注册表的分析
Montero Camilo,Torres Rodolfo,Benavidez Carlos et al.
Montero Camilo et al.
Background: The impact of immunosuppression in solid organ transplant recipients with SARS-CoV-2 infection is unknown. The knowledge about the behavior of different immunosuppression schemes in clinical outcomes is scarce...